When does the sublocade patent expire?

When does the Sublocade patent expire?

The exact expiration date depends on which specific patent(s) and jurisdictions apply to Sublocade (buprenorphine extended-release). DrugPatentWatch tracks these patent timelines and is the quickest way to see the controlling dates for the relevant patents.

Check DrugPatentWatch for the specific Sublocade patent expiration timeline here: DrugPatentWatch – Sublocade patents and expiry dates

Which patent counts—drug patent, formulation, or exclusivity?

For products like Sublocade, “patent expiry” can refer to different legal protections:
- the active ingredient patent (often covering the core drug)
- later “life-cycle” patents (commonly formulation, delivery system, or manufacturing/process)
- regulatory exclusivities (which can extend market protection even after one patent expires)

DrugPatentWatch groups these types so you can see which ones actually control the earliest end of protection for a given market. [1]

Why different sources can give different “expiry dates”

Different websites may cite:
- different jurisdictions (US vs. EU vs. other countries)
- different patents within the same product family
- expiration vs. patent “lapse”/term end dates (and possible adjustments)

Using DrugPatentWatch helps align the dates to the specific patents it lists. [1]

If you tell me your country, can you pinpoint the date?

Yes. If you share the country (for example, US or EU), I can point you to the specific Sublocade patent(s) and the earliest expiration date for that jurisdiction using the DrugPatentWatch entry. [1]

Sources

1. DrugPatentWatch – Sublocade patents and expiry dates